Quark Pharmaceuticals Presents Data on Synthetic siRNAs for Prevention of Ocular andInformation on Quark Pharmaceuticals Presents Data on Synthetic siRNAs for Prevention of Ocular and under Inner Ear section of the Health Articles & Reviews; Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference -based therapeutics, today announced that Elena Feinstein, M.D., Ph.D., Chief Scientific Officer, ... |
![]() |
|
Quark Pharmaceuticals Presents Data on Synthetic siRNAs for Prevention of Ocular and
by Horace_Robinson 05-15-2009, 06:09 PM
Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference -based therapeutics, today announced that Elena Feinstein, M.D., Ph.D., Chief Scientific Officer, presented a study titled, "siRNA Therapeutics for Prevention of Ocular and Inner Ear Sensory Cells Death," at the DxRx Summit: Nucleic Acid Diagnostics & Therapeutics.
More... |
|
Views 35
Comments 1
|
|
|||
|
|
![]() |
| Bookmarks |
| Currently Active Users Viewing This Article: 1 (0 members and 1 guests) | |
| Article Tools | |
| Display Modes | |
|
|
![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() |